Cytosorbents
CTSO
#9825
Rank
S$59.42 M
Marketcap
S$0.95
Share price
-1.20%
Change (1 day)
-24.00%
Change (1 year)

Cytosorbents (CTSO) - Cash on Hand

Cash on Hand as of June 2025 : S$13.22 Million

According to Cytosorbents's latest financial reports the company has S$13.22 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cytosorbents - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$4.45 M-76.11%
2023-12-31S$18.66 M-37.13%
2022-12-31S$29.68 M-57.88%
2021-12-31S$70.48 M-25.4%
2020-12-31S$94.48 M472.94%
2019-12-31S$16.49 M-46.03%
2018-12-31S$30.55 M31.9%
2017-12-31S$23.16 M205.19%
2016-12-31S$7.59 M-28.53%
2015-12-31S$10.62 M44.84%
2014-12-31S$7.33 M165.13%
2013-12-31S$2.76 M30.78%
2012-12-31S$2.11 M37.61%
2011-12-31S$1.53 M13.01%
2010-12-31S$1.35 M-39.3%
2009-12-31S$2.24 M-46.88%
2008-12-31S$4.21 M1284.88%
2007-12-31S$0.3 M-93.09%
2006-12-31S$4.4 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Meridian Bioscience
VIVO
S$0.10 B 698.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$2.43 B 18,315.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
S$1.65 B 12,395.10%๐Ÿ‡บ๐Ÿ‡ธ USA